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Abstract
Acute lymphoblastic leukemia (ALL) predominates in children ages 0-14 years and has
an excellent prognosis for cure with 5-year survival exceeding 90% in the United States.
However, not all children experience such positive outcomes. The purpose of this
quantitative, retrospective cohort study was to evaluate differences in survival of ALL
among children who reside in the 32-county Texas-Mexico border region. While factors
such as poverty and health insurance have been strongly associated with poorer cancer
outcomes, additional factors such as geographic isolation and treatment disparities are not
as well-documented in children. This study examined the association between use of
Texas Children’s Oncology Group (COG) pediatric research facilities and survival
among children in Texas diagnosed with ALL. This study used cancer incidence data
1995-2009 from the Texas Cancer Registry. Differences in survival and use of COG
facilities were investigated between children who reside within the 32-county TexasMexico border region and the combined remaining 222 Texas counties. Chi-square was
used to analyze area of residence, gender, race/ethnicity, and poverty status between
COG and non-COG reported cases. Logistic regression was used to examine ALL
survival differences between COG and non-COG facilities controlling for multiple
variables. COG affiliation alone was not a significant predictor of survival. An interaction
between race/ethnicity, region, poverty status, and COG facility affiliation was observed
as a significant predictor of poorer survival. The results of this study have the potential to
promote positive social change by implementing interventions addressing access to
equivalent pediatric cancer care in the 32-county Texas-Mexico border area.
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Chapter 1: Introduction to the Study
Introduction
Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer in the
United States, accounting for about one-quarter of all malignancies diagnosed in children
0-14 years of age (Hunger et al., 2012). Using the latest statistics from the American
Cancer Society (2016), approximately 3,000 children between the ages 0-14 years will be
diagnosed with ALL in the United States in 2016. Most of those children will be between
the ages of 2 and 5 years at the time of diagnosis (Robison, 2011).
The successful treatment of children diagnosed with ALL is considered one of
modern medicine’s greatest success stories against cancer, with current overall 5-year
survival rates of over 85% in developed countries (Pui, Mullighan, Evans, & Relling,
2012). Why 15% percent of children with ALL have poorer outcomes remains under
robust investigation. Such studies have revealed both clinical and demographic factors to
be involved in both short and long-term survival of the disease (Bhatia, 2011).
Acute leukemia is thus named as the disease progresses rapidly. The best
outcomes are marked by not only initial expedient intervention, but treatment targeted to
the patient’s specific disease metrics. The most advanced therapies for ALL are based on
several personal and biological metrics to assess the disease in a particular individual and
determine the best course of proven treatment. This risk-based treatment strategy requires
advanced technology testing, complex chemotherapy treatment, expert specialty care,
multiple visits, and long-term followup care. Specialized pediatric oncology research
centers that offer such protocols are members of the Children's Oncology Group (COG).
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Children diagnosed with ALL treated at these facilities experience survival approaching
95% (Pui, Pei, et al., 2012). In this study I examined the extent of COG facility
participation of children diagnosed with ALL in Texas. The purpose of this study was to
determine if facilities in Texas that have achieved COG membership offer prognostic
significance in pediatric ALL survival, and identify possible underserved areas for
positive interventions. This chapter describes key factors and issues related to the study.
Background of the Study
Texas is currently home to 15 pediatric oncology research centers that have been
designated COG institutions (COG, 2015). This organization is the world’s largest
pediatric cancer research cooperative, with over 200 facilities and 5,000 specialist
physicians (O’Leary, Krailo, Anderson, & Reaman, 2008). In a meta-analysis of pediatric
ALL survival, children treated at COG institutions were consistently found to have
significant survival advantage compared to children treated at facilities that are not
associated with COG membership (Bhatia, 2011).
During the time period examined in this study for ALL diagnosis (1995-2009),
COG facilities were located within eight major metropolitan areas covering east, west,
north, and central Texas, including the Panhandle area. The metropolitan areas of
Dallas/Fort Worth, San Antonio and Houston were all home to two COG facilities. No
COG facilities were located within the entire 32-county Texas-Mexico border area in
southern Texas (Cure Search, 2009). Travel of hundreds of miles would be required by
south Texas residents to reach any Texas COG facility. This is also true of any COG
facilities located in adjoining states of New Mexico, Oklahoma, Arkansas, and Louisiana.
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Figure 1 illustrates the 32-county Texas-Mexico border region and the locations of COG
facilities within the state of Texas.

Figure 1. The Texas-Mexico border area and COG facility locations.

Problem Statement
Despite continued advances in diagnostics and treatment protocols which have
resulted in increased survival, cancer remains the leading cause of disease-related
mortality in children and the second leading cause of death overall (American Cancer
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Society, 2016). A large area of the Texas population does not have access to COG
facilities. The Texas-Mexico border region of the state is particularly isolated from the
advanced care provided by pediatric oncology research centers. As discussed in Chapter
2, a lack of literature exists on access to care disparities in children. This population may
be medically underserved resulting in tragic and needless loss of life from a curable
disease.
Researchers have consistently shown that the type of facility administering care to
children diagnosed with ALL to be associated with survival (Bhatia, 2011; Hunger et al.,
2012). During the study period (1995-2009) the Texas-Mexico border area was void of
COG institutions that offer the best treatment regimens available for ALL.
The population of this area is primarily Hispanic and poor (U.S. Census Bureau,
2013). Researchers have repeatedly shown that both opportunity and cultural factors
result in the underrepresentation of minorities in clinical trials, the gold standard for
improved cancer treatments and survival (Ford et al., 2008). The multiple factors of
geographic isolation, poverty, and ethnicity pose a high risk in seeking treatment at more
local non-COG affiliated facilities, and thus poorer survival in the Texas-Mexico border
area.
Purpose of the Study
The purpose of this quantitative study was to examine the survival of children in
Texas diagnosed with ALL in regards to the facility of treatment, poverty status, gender,
race/ethnicity, and geographic location. Of additional interest was to document survival
of those children residing in the Texas-Mexico border region. There are no current
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published statistics for ALL specific to the Texas-Mexico border area. These data were
compared to the nonborder area of the state to identify possible disparities in survival of
the disease. A more thorough discussion of the variables examined and analyses is
covered in Chapter 3.
Research Questions and Hypotheses
The research questions reflect the need to examine survival of ALL in Texas in
more detail. The study seeks to examine several important questions:
1. What are the descriptive epidemiology statistics of childhood ALL in Texas?
These statistics will include ALL incidence, mortality, and survival rates for
children 0-14 years of age residing in Texas diagnosed 1995-2009.
2. Is there an association between COG facility affiliation and 5-year survival of
ALL?
Ho2: COG facility affiliation has no effect on 5-year survival of ALL.
Ha2: COG facility affiliation has an effect on 5-year survival of ALL.
3. Is there an association between COG facility affiliation and 5-year survival of
ALL controlling for race, place of residence, and poverty?
Ho3: There is no association between facility affiliation and 5-year survival of
ALL when controlling for race, place of residence, and poverty.
Ha3: There is an association between facility affiliation and 5-year survival of
ALL when controlling for race, place of residence, and poverty.
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Results will increase understanding of the burden of ALL in Texas, including the
expansive Texas-Mexico border area and identify specific target areas for further study
and public health interventions.
Theoretical Foundation
This study will use Krieger’s model of ecosocial theory, which poses as its main
question “who and what is responsible for population patterns of health, disease, and
wellbeing” and addresses social inequalities in health (Krieger, 2001; Krieger, 2002). The
researcher theorizes that geographical isolation as a barrier to the best risk-based
treatment is more a factor in pediatric ALL survival than poverty or Hispanic ethnicity.
This ecosocial theory of health encompasses more than the traditional theories in
epidemiology and disease, many of which focus primarily on the occurrence of disease
and causation. Krieger (2013) combines the social and ecological aspects of population
health, including physical environment, with more traditional epidemiologic theory.
Ecosocial theory examines the relationships between biological, social, political, and
economic aspects of population patterns of not only disease, but well-being (Krieger,
2001). One of the theory constructs stresses the role of discrimination and health
inequalities created by social systems that contribute to both disease and outcomes. The
result is a more complete epidemiological approach that may also be used to examine and
explain disease survival.
Further, Krieger (2013) argues that it is the also the obligation of epidemiologists
and researchers to become activists against injustice when such health disparities due to
social constructs are identified. Social change is a key construct to healthier populations.
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Rationale for the Research
Studies addressing racial/ethnic health disparities in children are few compared to
their adult counterparts (Flores, 2010). Limited data also exists on Hispanic children
diagnosed with ALL. The large Hispanic population of Texas including the
predominantly Hispanic population of the expansive Texas-Mexico border area presents
an opportunity to contribute to these areas of study and expand the literature available.
Pediatric cancers are much less common than the disease in adults. In addition,
pediatric cancers are unique in outcomes research in that the behaviors and actions of
others (parents) instead of the individual are a predominant factor in treatment and
survival. As a result pediatric studies are greatly lacking in the literature.
Using 1988-2008 SEER data, Goggins and Lo (2012) found poorer survival for
Black, Hispanic, Asian, and American Indian/Alaskan Native (AIAN) children diagnosed
with ALL when compared to non-Hispanic Whites. In an analysis of both SEER data and
cooperative group clinical trials, Bhatia (2011) reported higher mortality in both
Hispanics and Blacks, even when controlling for biological factors associated with poorer
outcomes.
In contrast, studies by Pui et al. (2003, 2012) at St. Jude Children’s Research
Hospital consistently found that with equal therapy, outcomes were the same for all
children, regardless of race. The authors suggested reported race/ethnicity health
disparities in the treatment of ALL are due to unequal healthcare access and differences
in treatment protocols. It is of note that the St. Jude studies only used White and Black
race categories, without regards to Hispanic ethnicity.
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For children who do not have access to these specialty facilities, advanced
treatment protocols, and quality followup care, the question of equal treatment/outcomes
is a moot point. O’Leary et al. (2008) reported that 90-95% of children in the United
States aged 0-14 years diagnosed with cancer are seen at a COG facility. To date, only
one state-based study assessing overall COG facility affiliation has been completed, with
87% participation reported in Georgia (Howell, Ward, Austin, Young, & Woods, 2007).
Nature of the Study
This population-based quantitative study used a retrospective cohort design
utilizing secondary data. This type of study is well-suited for population-based cancer
epidemiological studies, especially for rarer neoplasms. State cancer registries and/or
Surveillance, Epidemiology, and End Results (SEER) data are sources of secondary data
for many such population studies. This study compared groups of children in Texas
diagnosed with ALL in terms of survival and the association with the type of facility
administering care, geographic area of residence, race/ethnicity, gender, and poverty
status. All data are secondary, having been previously collected by the Texas Department
of State Health Services through the Texas Cancer Registry (TCR), who mandated by
state law maintain a registry of all incidence cases. Appropriate rates, chi-square, and
logistic regression analyses were conducted. More detailed discussions of study
methodology specifics are discussed in Chapter 3.
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Definitions
Acute lymphoblastic leukemia (ALL): The most common cancer in children
characterized by the abnormal production of immature lymphocytes, a specific type of
white blood cell, in the bone marrow and blood stream (Pui, 2012).
Children’s Oncology Group (COG) facility: One of 12 member-affiliated
pediatric oncology specialty centers located within the state of Texas. The defining factor
of these facilities is pediatric cancer research including clinical trials (COG, 2016).
Risk-based treatment: Treatment based on a comprehensive diagnostic profile that
considers several clinical and biological factors, including advanced morphology,
immunology, genetics, and molecular laboratory analyses. This difficult process requires
the most advanced technology and trained personnel, and thus is very expensive (Carroll
et al., 2003).
Texas Cancer Registry (TCR): A statewide population-based registry in Texas that
collects cancer incidence and mortality data per state mandated law (TCR, 2014). The
registry meets all standards set forth by the National Program of Central Cancer
Registries of the Centers for Disease Control. Data from the TCR have the highest quality
certification from the North American Association of Central Cancer Registries (TCR,
2014).
Abstract report: The original document submitted to the Texas Department of
State Health Services/TCR from a healthcare facility reporting a case of ALL or other
cancer. Per state law, a facility is required to file a report for any patient seen with cancer,
even if the patient was diagnosed/treated prior at another facility (TCR, 2014). As a
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result, a report should be received from every facility each cancer patient visits,
regardless of the reason/condition for admission.
Assumptions
While the incidence data required for this study from TCR were subjected to
rigorous quality assurance protocols and have achieved high national standards, the
chance for miscoding and other inaccuracies exists. Data are assumed to reflect actual
ALL cases and other coding as to age and address at time of diagnosis correct. Facility
identification and address from the reports is assumed accurate and was used only to
indicate that the patient was seen at that facility. No followup was made to confirm or
refute any data element.
Scope and Delimitations
Cancer data collection at TCR is passive, relying on reports from healthcare
facilities throughout the state, including hospitals, cancer treatment centers, and
pathology laboratories. Cancer is a reportable condition to the state health department per
Texas state law, with reports required to be sent to TCR within 6 months of initial
diagnosis or admission (TCR, 2014). Vital status and date of death are contained in these
reports and included in the incidence database. The scope of this study was limited to
ALL diagnosed among children residing in the state of Texas. Further comparisons
between state and national populations are common in cancer epidemiology studies.
Cancer incidence reports in this study were limited to the following:
1. Reports must have a diagnosis date falling between January 1, 1995 and
December 31, 2009.
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2. Patient must be recorded as a resident of the state of Texas at the time of
diagnosis.
3. Patient must be less than 15 years of age at the time of diagnosis.
Limitations
The exact reasons as to why an individual did not visit a COG facility cannot be
determined from this study. Given all COG facilities provide care regardless of inability
to pay along with multiple financial and transport support resources (Cure Search, 2009)
physical access to such facilities must be considered. Support services are also provided
in Spanish and include local providers. Given the citizenship status of many residents
along the Texas-Mexico border, this must also be considered in seeking care from
institutions located long distances from resident communities.
The possibility exists that facilities did not file cancer reports with the TCR. This
could result in an incomplete assessment of patient care. However, COG facilities not
only maintain a cancer registry for reporting per state law but also to meet criteria for
membership in the COG research collaborative. COG facilities not reporting should be
minimal and possibly even nonexistent.
The possibility exists that cancer patients may obtain care at a COG facility in
another state. However, given the location of the Texas border area and the highly-rated
and professionally respected facilities within the state, this would probably be a rare
occurrence. When considering COG facilities, the locations in neighboring states are
even further from in-state locations. This further illustrates the geographic isolation of
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this area from pediatric oncology research facilities. Visits to out-of-state facilities were
noted in the analyses.
Most Hispanic children in Texas reside in the border area, and populations of nonHispanic Whites and other races are extremely low. As childhood cancer is an uncommon
condition compared to adult cancers, many other areas of the state will not have the
population size to produce the case counts needed to calculate stable incidence and
mortality rates. Only the Dallas/Fort Worth and Houston metropolitan areas contain a
Hispanic population large enough for comparison to areas located within the border area.
As a result this study was limited to comparing Hispanic children in the Texas border
area to Hispanics and non-Hispanic Whites residing in the collective nonborder counties
of Texas. It is of note there were four COG facilities in the Dallas/Fort Worth and
Houston metropolitan areas during the study period.
Life tables representing the survival of the general United States
population are used in calculation of relative survival. The life tables are used in
substitution of a cancer-free cohort for comparison to observed survival of cohorts of
individuals diagnosed with cancer. This methodology provides measures for comparing
survival between groups defined by variables such as race/ethnicity, and is currently used
in NCI/SEER statistical publications (Howlader et al., 2016). However, at the time of this
research specific life tables for Hispanics were not available. As a result, relative 5-year
survival was only calculated for all races combined.
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The question of actual treatment, if any and the extent of any treatment protocols
were not assessed and out of the scope of this study. Howell et al. (2007) and O’Leary et
al. (2008) only examined documented facility visits and not actual treatment.
Significance of the Study
Not all children in the United States have benefited from the advances in
treatment and increased survival of ALL. This has proven especially true for minority
children and children from low SES families. However, many of those cancer studies
used data provided by the Surveillance, Epidemiology, and End Results (SEER) program
of the National Cancer Institute (NCI). This program consists of 18 state and city cancer
registries, representing 26% of the United States population (SEER, 2009). Jamal, Siegel,
Xu, and Ward (2010) published United States childhood cancer survival statistics using
only SEER data. Siegel et al. (2012) reported 91% survival for ALL cases diagnosed
2001-2007 using only a SEER dataset.
The state of Texas is not currently included in the SEER program. This study
offers a unique opportunity to examine ALL among a large and unique population of
Hispanic children and identify potential health disparities. The large geographic layout of
the state, larger than many European countries, provides the opportunity for unique
geospacial comparisons. This study utilizing 15 years of data created a substantial
pediatric cancer dataset for epidemiological analyses that has previously not been
examined.
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Significance to Social Change
It was estimated that in 2016 over 1.6 million new cases of invasive cancer would
be diagnosed in the United States with over 595,000 deaths from the disease, an average
of almost 1,600 per day (ACS, 2016). Cancer is only surpassed by heart disease in the
United States as the overall leading cause of death (Jemal, Siegel, Xu, & Ward, 2010).
This gap has narrowed substantially over recent years, and since 1999 cancer has become
and remains the leading cause of death for people younger than age 85 years (Jemal et al.,
2010).
Children also die of cancer, and some of treatable and survivable malignancies
such as ALL. When examined in further detail, many of these children are found to have
similar demographic characteristics associated with mortality. The goal of this study was
to further identify such health disparities, and reveal the needless suffering and death of
children living in the United States.
The debate exists whether healthcare is a privilege or a right. Opinions have
changed over the years, and the Patient Protection and Affordable Care Act of 2010
allowed many access to healthcare that previously were without health coverage.
However, many states including Texas refused to implement the policy. Due to politics,
many Texas families still do not have health insurance coverage. The health of the
population should be a priority issue, especially for children. This study seeks to further
illustrate the urgent need for policy and social change at all levels for equality in health
care.
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Summary
Acute lymphoblastic leukemia (ALL) is the most common cancer in children, and
one of the most treatable malignancies with some facilities reporting overall 5-year
survival rates of 95% (Pui, Pei, et al., 2012). Successful outcomes are influenced by
several factors, including timely diagnosis, administration of proven effective risk-based
treatment protocols, adherence to treatment, and continued followup. Access to such care
can be limited by geographic location and SES. Researchers have had mixed results when
examining race, ethnicity, and survival, and studies focusing on Hispanic children have
been limited. In this study I seek to provide data from a unique population that has not
been previously examined to contribute to this important area of study.
This study examines the survival of children residing in Texas diagnosed with
ALL 1995-2009. The purpose was to examine if COG membership holds prognostic
significance on ALL survival. Large areas of Texas are isolated from COG facilities and
residents must travel hundreds of miles to obtain expert pediatric oncology care. Such
barriers have been associated with poorer cancer outcomes, including survival.
Chapter 2 focuses on the complete background of ALL, a condition that
physicians and researchers alive today remember was 100% fatal during their early
careers. While great advances have been made in ALL survival, a significant number of
children still die from the disease. Chapter 3 focuses on the data used in this study, study
design, and the data analyses conducted. Chapter 4 reveals the results of the data analyses
and Chapter 5 provides a discussion and interpretation of these results, as well as future
implications.
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Chapter 2: Literature Review
Introduction
The purpose of this study was to examine if affiliation with Children’s Oncology
Group (COG) facilities for treatment of childhood acute lymphoblastic leukemia (ALL)
was associated with improved 5-year survival. These facilities offer the most
comprehensive and effective treatments available administered by expert specialty
physicians. Large areas of Texas are isolated from such facilities. It is the hypothesis of
the author that this isolation creates an access to care barrier resulting in significant
poorer survival.
Several variables have been documented as having an association with poor ALL
survival in children. These established predictors of ALL 5-year survival among children
include facility-type associated with treatment, geographic area of residence, and
residence-area poverty. State cancer registry data is commonly used in such studies. Kent
et al. (2009) conducted a retrospective design study of childhood leukemia survival using
cancer incidence data 1996-2005 from the California Cancer Registry. Howell et al.
(2007) used data from the Georgia Cancer Registry 1998-2002 to examine COG
participation among pediatric cancer patients residing in Georgia. Goggins and Lo (2012)
used SEER data 1988-2008 to examine disparities among children diagnosed with ALL.
Gutierrez, Cheung, Zhuge, Koniaris, and Sola (2010) used Florida cancer registry data to
study COG efficacy in treating childhood malignancies. This quantitative retrospective
cohort study used incidence data from the Texas Cancer Registry (TCR) for diagnosis
years 1995-2009.
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Literature Search Strategy
The primary search engine used in the literature review was PubMed, accessing
primarily the MEDLINE database. Key search terms were "acute lymphocytic leukemia"
and "Children's Oncology Group." Additional terms used were "survival," "childhood,"
"pediatric," "access to care," "treatment," and "health disparities." In addition several
authors names were used who are considered experts in the field, such as Ching-Hon Pui,
MD, and Smita Bhatia, MD, PhD.
Several textbooks from the author's private collection were also used from both
public health and clinical education and training. Additional texts and peer-reviewed
journals from the Texas State Department of Health Services library were also used.
Children's Oncology Group Facilities
The specialty of pediatric oncology is a relative new area of medical expertise.
The American Board of Pediatrics did not offer an examination for a subspecialty in
hematology/oncology until 1974 (Wolff, 1991). According to Health Grades (2009), the
nation’s leading independent health care rating organization, fewer than 2,000 pediatric
oncologists/hematologists combined practice in the United States, with only 169 in the
entire state of Texas. Beginning in the 1950s, several groups were organized in the
United States to focus on childhood cancer research. Over the next three decades these
included the Cooperative Acute Leukemia Group A (CALGA) which soon became the
Children’s Cancer Study Group (CCSG), the Southwest Oncology Group (SWOG), the
Cooperative Acute Leukemia Group B (CALGB), the National Wilms Tumor Study
Group (NWTSG), and others (Wolff, 1991). In 1986 several merged to form the Pediatric

18
Oncology Group (POG) eventually representing over 40 institutions. In 2000 all pediatric
groups were merged into the Children's Oncology Group (COG), currently the world’s
largest pediatric cancer research organization with over 200 member institutions
conducting clinical trials (American Academy of Pediatrics, 2009). During the time
period studied, 12 COG institutions were located within the state of Texas (Cure Search,
2009).
Nationally it is estimated that 90-95% of childhood cancer patients aged 0-14
years are treated at COG facilities (O’Leary et al., 2008). However, analyzing
Surveillance, Epidemiology, and End Results (SEER) data for pediatric cancer cases
diagnosed 1992-1997 (N = 10,108) from 11 SEER registries, Liu, Krailo, Reaman, and
Berstein (2003) found only 71% had been registered at a COG facility. As the TCR is not
a SEER registry, Texas data were not included in the Liu et al. study. Carrol (2003) had
reported previously over 80% of children will ALL in the United States would be treated
at a COG facility.
Researchers have repeatedly shown children with ALL treated at COG facilities
had significant improved survival (Bhatia, 2011). St. Jude Children’s Research Center
(2010) reported 94% 5-year survival for ALL and 77% for AML, well above published
national survival rates. Texas Children’s Hospital (2010) reported increasing ALL 5-year
survival in infants from 20% to 50% through clinical trials, with their developed therapy
protocol becoming the national standard. The improved survival of ALL through clinical
trial participation at pediatric oncology research centers has been documented as far back
as 1983 (Meadows et al., 1983).
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In a study of COG facility access in the state of Georgia, Howell et al. (2007)
found 87% participation for children aged 0-14 years, with no disparity between Black
and White children. For children diagnosed with ALL, 5-year survival was 86.3% for
COG institutions and 53.3% for other facilities. No regional differences within the state
were examined. This was in part due to the multiple COG facilities located in several
states bordering Georgia. There were no areas within Georgia fully isolated from a COG
pediatric oncology facility.
This study used Texas population-based cancer data, collected directly by the
state of Texas, and not a national database.
Health Disparities
Health disparities refer to differences in health, healthcare, and health outcomes
based on personal demographic and socioeconomic factors (Bhatia, 2011). The U.S.
Department of Health and Human Services (2000) targeted the elimination of health
disparities as the second major public health objective to be achieved by the year 2010.
These population-specific factors include race, ethnicity, socioeconomic status (SES),
and geographic location. Health disparities are uniquely involved in childhood cancer in
that these factors can apply to both the child diagnosed with cancer and parents seeking
to provide care. Unfortunately, little improvement has been made in overall cancer health
disparities despite decades of studies and public health interventions (Kagawa-Singer,
Dadia, Yu, & Surbone, 2010).
In a self-assessment of the goal of eliminating health disparities by 2010, the U.S.
Department of Health and Human Services (2012) found that no state had achieved the
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set goal of health insurance coverage, with Texas having the highest percentage of
uninsured residents. More of the stated health objectives actually worsened (24%) than
were achieved (23%), and was even more pronounced among Hispanics. In specific
regards to health disparities, 80% of the targeted objectives remained unchanged. As a
result, health disparities and basic healthcare access remained target goals for
improvement by 2020. Even with these national targeted interventions, the literature for
health disparity interventions addressing mortality and chronic disease in non-infant
children remains severely limited (Flores, 2010).
Race/Ethnicity
Hispanic children in the United States experience the highest incidence rate of
ALL (ACS, 2012). Racial/ethnic minorities experience poorer cancer outcomes when
compared to their White counterparts (Kagawa-Singer et al., 2010). Black, Hispanic, and
American Indian/Alaskan Native (AIAN) children diagnosed with ALL have also been
shown to have overall worse survival when compared to non-Hispanic Whites (Bhatia,
2011).
The mechanisms behind race/ethnicity and effect on ALL survival remain under
investigation. Using population-based studies, Bhatia (2011) and Liu et al. (2003)
reported that even with equal treatment Black, Hispanic, and AIAN children still
experienced worse survival. In a followup examination, Goggins and Lo (2012) also
reported poorer ALL survival for minorities when compared to non-Hispanic Whites
using SEER data.
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Examining cooperative group trial data 1990-2005, Hunger et al. (2012) found
poorer survival in Black and Hispanic children treated for ALL. Trend analyses
conducted revealed that survival had increased for Black children 1990-2005, but
decreased for Hispanics. The authors cite higher-risk biological factors (T-cell vs. B-cell
origin) and genomic mutations at possible explanations.
However, in institutional studies, Pui et al. (2003, 2012) found that with equal
treatment, children of all races/ethnicities experienced the same outcomes, regardless of
disease metrics at diagnosis. This would indicate that race/ethic differences are more
associated with variances in complete administered treatment protocols.
Socioeconomic Status
Socioeconomic status (SES) plays a major role as a determinant in healthcare and
health. The social stratification of individuals based on education, occupation, income,
and residence in turn influences health status, access to care, and decisions about
healthcare (Kagawa-Singer, Dadia, Yu, & Surbone, 2010). Later stage at diagnosis and
less aggressive treatment have been identified as key risk factors in low SES groups
(Byers et al., 2008). For many conditions, when SES factors are controlled disparities are
greatly reduced or even eliminated. Social factors play a larger role than biologic factors
in explaining racial/ethnic disparities (Byers et al., 2008).
Characteristics associated with SES have a substantial impact on both cancer
incidence and mortality. For adult cancers, SES and poor outcomes can be in part
attributed to lifestyle choices (tobacco use, diet, exercise, other behaviors, etc.) and
nonuse of cancer screening. These factors are not as closely related to ALL and other

22
cancers in children. There are few identified lifestyle risk factors (parent or offspring) for
childhood ALL and no screening protocols exist.
Where prevention and early detection are mortality hallmarks of such adult
neoplasms as prostate, cervical, colorectal, and breast cancer, ALL survival relies solely
on precise timely diagnosis and treatment. The costs, time investment, and required
resources between screening/prevention and treatment strategies are substantial. Even
with comprehensive health insurance, associated out-of-pocket expenses such as
copayments, travel, missed working hours or even employment termination resulting in
lost income, and homecare expenses can be substantial (Bona et al., 2014). The poor
suffer disproportionate financial losses, and costs associated with childhood cancer can
cause families not in poverty to fall below the federal poverty level (Bona et al., 2014).
Comprehensive, optimal treatment for ALL involves repeated visits for two and
often three years (Diller, 2011). Even under the most favorable financial conditions such
a treatment protocol presents many challenges. Parsons (2006) reported that even with
health insurance families with a child receiving treatment for ALL spent up to one-third
of their after-tax income on related expenses. In 2007, 62% of all bankruptcies in the
United States were caused by medical expenses, with 75% of those claims affirming
having health insurance (Himmelstein, Thome, Warren, & Woolhandler, 2009).
For poor families without health insurance the situation can be especially
devastating both financially and psychologically. Even such basic needs as lack of
nutritious food can have serious effects. Margolin et al. (2011) reported undernourished
children diagnosed with ALL suffer 2.5 times the mortality from the disease.
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The SES gradient, however, in childhood cancer is not always as linear as in adult
cancers. In a study of California children diagnosed with ALL Kent et al. (2009) found
that survival did not differ among SES levels for Hispanic children. The authors theorized
that geographic location and access to the best care was a survival factor among Hispanic
children in California.
Geographic Location
The U.S. Department of Health and Human Services (2010) defined attaining
adequate access to health care as being received timely, achieving the best results
possible, and having three defined components:
1.

Gaining entry into the health care system.

2.

Getting access to sites of care where patients can receive needed services.

3.

Finding providers who meet the needs of individual patients and with whom
patients can develop a relationship based on mutual communication and trust.
(p.141)

Children and their parents who live in geographically isolated areas are challenged to
meet any or all of those criteria, especially those who are poor with language barriers and
are in need of advanced specialty oncology care.
Youlden et al. (2011) found that children diagnosed with cancer residing in
remote areas of Australia had significantly lower survival compared to children living in
cities. This was especially true for children diagnosed with ALL. Schillinger et al. (2011)
found place of residence, and not poverty, was more significant in survival among
children diagnosed with ALL in England.
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Goodwin, Freeman, Mahnken, Freeman, and Nattinger (2002) used incidence,
mortality, and survival to reveal geographic variations in breast cancer survival in the
United States. Geographic variations in cancer survival have been identified in Europe,
particularly when examining breast cancer (Sant et al., 2009). In both the American and
European studies, variations in access to care, treatment protocols, adherence, and
followup are viewed as likely reasons for these differences. In examining European
Cancer Registry childhood cancer data, Gatta et al. (2005) found higher survival for
lymphoid leukemia in Western Europe compared to Eastern Europe. Access to higher
quality treatment was considered the reason for this discrepancy.
One geographically isolated area of the United States that has been studied is
Appalachia, a mountainous region that stretches from New York down to the costal
southern states. Characteristics of this area include poor health, poverty, and low
education levels (Behringer et al., 2007). This region suffers from higher and premature
mortality from many conditions including cancer (Wingo et al., 2008). The size and
geographic isolation of many parts of the Appalachia area creates a distance to care
barrier. High poverty and the unique cultural characteristics of the area create additional
barriers to health care.
The Texas-Mexico border represents a very similar geographically isolated and
culturally diverse region. In addition, over 5 million children in the United States have
undocumented parents with over half living at twice below the federal poverty level
(Urban Institute, 2010). This environment not only restricts access to quality care in the
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United States, but forces many Texas residents to cross the Rio Grande and seek care and
medications in the border towns of Mexico (Rivera, Ortiz, & Cardenas, 2009).
At over 268,000 square miles Texas is physically the second largest state in the
Union with 254 counties and a population of over 26 million, 27% of which are under the
age of 18 years (U.S. Census Bureau, 2013). Texas is home to a large Hispanic
population (38.2%), with the border area population 74.1% Hispanic (U.S. Census
Bureau, 2013).
The border counties of El Paso, Hidalgo, Cameron, and Webb are among Texas’s
most populated, ranked 6th, 7th, 11th, and 21st respectively (U.S. Census Bureau, 2013).
The border cities of El Paso, Brownsville, Laredo, and McAllen account for almost half
the border area population, and are among the areas located furthest from COG facilities.
Over 705,000 children below the age of 18 years reside in the Texas-Mexico border area
(U.S. Census Bureau, 2013).
In 2004, Texas Children’s Hospital, a COG facility in Houston, opened a satellite
clinic in McAllen to provide some oncology services to children in south Texas. Clinical
trials, the defining characteristic of COG membership, were not conducted during the
study period. Clinical trials offer the latest innovative and most effective therapies
available, and as a result children treated at these facilities have a significant survival
advantage (Bhatia, 2011). Substantial progress and continued advances in childhood
cancer treatment are the result of high-participation clinical trials at COG facilities
(Siegel, Naishadham, & Jemal, 2012). Survival for ALL based on clinical trial strategies
administered in COG facilities has collectively exceeded 90% (Robison, 2011).
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As with much of Texas, a large portion of the border area is also rural. Rural areas
have been identified as having higher poverty rates and increased health disparities
(Eberhardt et al., 2001). Access to physicians in general can be a barrier to persons living
in rural areas. Van Dis (2002) reported that while 20% of persons in the United States
lived in rural areas, only 9% of the country’s physicians practiced in rural areas. The
distribution of specialist physicians poses an even larger challenge.
The predominantly Hispanic Texas border area is not only the poorest area of
Texas, but one of the highest poverty areas of the United States (U.S. Census Bureau,
2010). This is especially true for persons under 18 years of age. Over 37% of children
residing in the 32-county border area were living in poverty in 2008 compared to 22.5%
for the state and 18.2% for the United States (U.S. Census Bureau, 2010).
McCarthy et al. (2009) reported that Texas ranks last in the nation for the number
of children with health insurance. The largest concentration of these uninsured children
occurs along the Texas-Mexico border (U.S. Census Bureau, 2010). The U.S. Census
Bureau (2010) reported that for 2008 the population of the 32-county Texas-Mexico
border area was 80% Hispanic, with some counties reporting over 95% persons of
Hispanic origin. Researchers have shown that Hispanics are much more likely to be
employed in occupations without employer-based benefits (Escarce & Kapur, 2006).
The small communities in the border area known as "colonias" suffer from
extreme poverty and poor health (Texas Secretary of State, 2014). These migrant
neighborhoods are home to over 400,000 people and often lack the most basic of services
and infrastructure including electricity, water, sewage, decent housing, and paved roads
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(Texas Secretary of State, 2014). These areas are isolated from even the most basic
medical and dental care.
Literature Review of Pediatric ALL Epidemiology/Survival
For the years 2007-2011, the overall incidence rate for ALL among children aged
0-14 years in the United States was 4.2 per 100,000 population, with a mortality rate of
0.3 per 100,000 (Howlader et al., 2014). While males experienced a slightly higher
incidence rate than females, mortality rates were the same for both genders (Howlader et
al., 2014). Males have been shown to have poorer outcomes (Kaden-Lottick et al., 2003;
Hossain, Xie, & McCahan, 2014).
Hispanic children experienced the highest incidence, and Blacks the highest
mortality. Barrington-Trimis et al. (2015) reported that ALL incidence in Hispanic
children was increasing at a statistically significant higher rate non-Hispanic children.
Kaden-Lottick et al. (2003) reported poorer survival in Hispanic children when compared
to non-Hispanics. However, as described earlier, all of SEER-based studies and many
nationally published statistics do not include states/areas such as Texas with large
Hispanic populations.
Age at Diagnosis
Age at diagnosis is a key prognostic factor in risk classification of ALL. Ages 1-4
years of age experience the highest incidence and have the most favorable outcomes, with
survival over 90% in the United States (Siegel, Naishadham, & Jemal, 2012). Infants
younger than one year of age experience poor outcomes with 46% survival (Hossain et
al., 2014). Survival of childhood ALL decreases with each additional year of age
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beginning with diagnosis at 5 years of age, with survival decreasing to 57% for ages 1519 years (Hossain et. al., 2014).
Importance of Risk-Based Treatment
Four major types of leukemia are identified (Lichtman, 2008):
1. Acute Lymphoblastic Leukemia (ALL)
2. Acute Myeloid Leukemia (AML)
3. Chronic Lymphoblastic Leukemia (CLL)
4. Chronic Myeloid Leukemia (CML)
The terms “acute” and “chronic” refer respectively to whether the progression of the
disease is rapid or slow. The leukemia type is then designated by the blood cell type
affected. Lymphoblastic leukemia refers to the uncontrolled proliferation of
lymphoblasts, an immature type of white blood cell (Torpy, Lynm, & Glass, 2009).
Myeloid leukemia is defined by the proliferation of cells other than lymphoblasts, such as
other white blood cells, red blood cells, and platelets in the bone marrow (Altman & Fu,
2011). Myeloid leukemia is rare in children and has a much poorer prognosis. The vast
majority of childhood leukemia cases are acute - ALL and AML account for
approximately 95% of all childhood leukemia cases (Onciu & Pui, 2012). Chronic
leukemia in children is rare.
ALL is further classified into subgroups based on the pathobiology of the
leukemic lymphoblasts. The identification of the type of lymphoid cell from which the
disease originates is of great importance and determined at diagnosis. Approximately
85% of childhood ALL is of B-cell origin (Margolin, Rabin, Steuber, & Poplack, 2011).

29
Further classification based on cell morphology, immunology, cytogenetics, and
molecular structure define the disease into even smaller sub-types. Detailed classification
systems include the French-American-British (FAB) scheme and the World Health
Organization (WHO) criteria (Onciu & Pui, 2012). With improved genetic analyses, these
classifications continue to be expanded.
Based on the multiple criteria of these systems, approximately 85% of children
diagnosed with ALL are classified into the low risk category associated with the most
favorable outcomes (Onciu & Pui, 2012). Basic criteria of this category include B-cell
type disease diagnosed at 1-9 years of age, low leukocyte counts, and no testicular or
CNS lesions (Pui, 2012). The detailed stratification of children into these risk groups has
greatly improved the selection, administration, and effectiveness of treatment and
subsequent survival (Seibel, 2008). Recent advances in molecular medicine, in particular
pharmacogenomics which examines both patient and malignant leukemia cell genetic
features, has shown great promise (Pui et al., 2008). Researchers continue to develop the
most accurate risk categorization of ALL to administer the most effective treatments at
the appropriate levels (Siebel, 2008).
Treatment of ALL Protocols
Unlike solid tumors where surgery or radiation can be specifically directed to a
particular location, hematologic malignancies require a systemic approach. Solid tumors
can often be detected and removed surgically at the early stages before the malignancy
spreads which greatly improves the odds of successful treatment. Prior to the 1950s a
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diagnosis of leukemia in a child was virtually a death sentence with zero treatment
options available (Margolin et al., 2011).
The selection of St. Jude, the patron saint of lost causes, in naming the now
famous pediatric cancer research center in Memphis, Tennessee, directly reflected the
general outlook in the early 1960s towards treating children with cancer. At that time a
child diagnosed with ALL had less than 10% chance of survival (Hunger et al., 2012). As
late as 1965 many medical experts were still publishing articles harshly criticizing
research in childhood leukemia (Lichtman, 2008).
With continued drug developments, improved multi-treatment components, and
more focused risk-based treatment including cytogenetics, 10-year survival for ALL in
children improved from 20% in the early 1970s to over 80% by 1995 (Margolin et al.,
2011). This is an important statistic as once 10-year survival is achieved the chance of
relapse is very low. For low-risk categories of ALL treated with optimal protocols, 5-year
survival progressed to exceed 90% (Pui et al., 2009). Many of the therapeutic agents
initially identified and administered remain in present-day treatment protocols for ALL in
children.
Preventing Disease Relapse
Pui et al. (2008) reported that initial clinical remission, in which there is no
physical or microscopic evidence of leukemia, could be achieved in 99% of children
diagnosed with ALL. This first step in the treatment of ALL is known as the induction
phase where the selected chemotherapy drugs and dose levels are administered over a
period of several weeks (Margolin et al., 2011).
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Leukemic cells can often reside in the central nervous system (CNS) where some
antileukemic drugs are not effective. It is imperative that during the induction phase no
residual leukemic cells remain in the blood, bone marrow, or CNS. Physicians began
using radiotherapy in the 1960s and 1970s to prevent CNS relapse in ALL cases, but this
was later questioned due to the dangers of exposing a child’s brain and/or spinal cord to
radiation (Margolin et al., 2011). Based on continued studies today most COG pediatric
oncologists only advocate cranial radiation at diagnosis for the most high-risk ALL
groups. With the improved success of risk-based chemotherapy, Pui et al. (2009)
recommended eliminating radiotherapy completely in ALL treatment. Sophisticated and
complex testing only available at pediatric oncology specialty facilities is needed to
determine the risk/benefit ratio of various ALL treatments (Margolin et al., 2011)
Late Effects of Treatment
The successful treatment of ALL with toxic anticancer agents created additional
problems for researchers and clinicians to address, noted from the first clinical trials. The
synthesis of less-toxic compounds improved side effects, but adverse conditions
remained a problem. Immunosupression was eventually successfully treated with
antibiotics. Radiotherapy, used in the 1960s and 1970s to prevent CNS relapse in ALL
cases, was later reserved for only the most high-risk categories due to the dangers of
exposing a young child’s brain to radiation (Margolin et al., 2011).
Oeffinger et al. (2006) found that childhood cancer survivors in general were
more likely to have later diminished health status and die prematurely when compared to
adults who were not diagnosed with cancer as a child. Two out of three childhood cancer
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survivors developed complications due to therapy, with 25% of childhood cancer
survivors developing a severe condition (Oeffinger et al., 2006) Survivors of ALL in
particular are at risk for second neoplasms, neurological problems, cardiac dysfunction,
infertility, and growth failure (Mody et al., 2008). Psychological and psychosocial
problems, especially in individuals who received cranial radiation, are also of major
concern in the ALL survivor (Zeltzer et al., 2009). Mertens (2007) reported significant
mortality risk from treatment-related complications for up to 25 years after initial
childhood diagnosis.
Given the chance of relapse and the high incidence of associated late effects from
ALL treatment, routine followup care is essential (Robison, 2011). The specific
treatment-related risk factors of ALL must be continuously monitored for the earliest
possible detection. As with initial evaluation and subsequent treatment, comprehensive
risk-based care from the most skilled professionals in continued followup care is vital to
long-term survival. Margolin et al. (2011) stressed that in addition to blood therapy and
infection control, addressing nutritional needs and providing psychosocial support for the
patient and family must also be included in any treatment protocol. Cultural issues must
also be addressed (American Academy of Pediatrics, 2009). This comprehensive care
must also be accessible. The American Academy of Pediatrics reported that many
children diagnosed with cancer experience barriers, including having to travel long
distances to facilities that deliver such care.
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Summary
This chapter reviewed the treatment of pediatric ALL, and key factors associated
with that treatment and survival. The successful treatment of ALL is one of the few major
victories in treating children with cancer. Once 100% fatal, through research and
technology survival in the United States has now exceeded 90%. Some COG facilities
have even pushed survival of pediatric ALL to 95%.
However, not all children in the United States have access to such expert care, and
survival can vary due to several factors. Physicians and researchers at COG facilities
have revealed that when treating the disease there are no clinical or biological factors that
reduce survival with equal treatment. Even demographic factors such as gender, race, and
ethnicity have no effect when the best risk-based treatments are applied. Thus, the
reasons for poorer survival must be explained outside of the clinical environment. In
order for children to experience the same level of survival, each child much be treated
with the same level of care throughout their disease process available only at COG
facilities.
This study further examines the effectiveness of COG facility-affiliation in the
treatment of pediatric ALL, and in a population previously not studied. Additional
covariate variables were also examined. Chapter 3 describes the variables used in this
research and the analyses conducted.
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Chapter 3: Methodology
Introduction
The purpose of this study was to determine if facilities in Texas with COG
membership offer prognostic significance in pediatric ALL survival. This chapter will
discuss this study's design, study population, data collection, variables of interest, and
data analyses. Quality assurance, confidentiality, and protection of human subjects are
also addressed.
Research Design and Rationale
The design used for this study was a retrospective cohort design. This type of
study is well-suited for population-based cancer epidemiological studies, especially for
rarer neoplasms. State cancer registries and/or Surveillance, Epidemiology, and End
Results (SEER) data are sources of secondary data for many such population studies.
Data for this study was obtained from the Texas Cancer Registry (TCR).
This study was approved by the Walden University Institutional Review
Board (IRB), approval number 11-04-16-0101571. As no confidential data elements were
used in the analyses, no approval from the Texas Department of State Health Services
(DSHS) IRB was needed. DSHS provides requested datasets for research from their
available public-use list at no charge, requiring only a signed data use agreement.
The study population for this study was all individuals residing in the state of
Texas diagnosed with ALL 1995-2009 at age 14 years or younger. All incidence data
used in this study was previously collected by TCR via passive surveillance through
abstract reports, primarily from Texas hospitals and cancer treatment facilities. The
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reports then must complete a series of quality assurance protocols to ensure high data
quality before being accepted as a legitimate incidence case of cancer in Texas. By state
law, TCR maintains a statewide cancer incidence database from these reports.
In addition to specific cancer information, these reports include key fields for
epidemiological study such as reporting facility, race/ethnicity, the address of residence
at diagnosis, date of birth, date of diagnosis, vital status, and date of death (Table 1). TCR
meets all standards of the Centers for Disease Control (CDC) National Program of
Cancer Registries (NPCR) program, and is certified by the North American Association
of Central Cancer Registries (NAACCR) for consistently achieving high data quality
standards (TCR, 2010).
The dependent variable in this study was 5-year survival. The independent
variables were COG facility status (yes/no), geographic region of residence
(border/nonborder), and poverty status (>= 20% for residents of county based on census
tract data from U.S. Census Bureau). Galster (2012) found that most negative effects
associated with poverty begin to manifest and progress rapidly once a neighborhood
exceeds an overall 20% poverty rate.
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Table 1
Study Variables
Variable

Type

Coding

Source

Date of Birth

Date

MM/YYYY

TCR

Date of Death

Date

MM/YYYY

TCR

Gender

Binomial

Male/Female

TCR

Race/Ethnicity

Categorical

NHW,H,B,O*

TCR

Date of Diagnosis

Date

MM/YYYY

TCR

Age at Diagnosis

Continuous

0-14 Years

TCR

Residence County

Binomial

Border/Nonborder

TCR

Vital Status

Binomial

Alive/Dead

TCR

COG Facility

Binomial

Yes/No

TCR

Poverty Status

Binomial

>=20% = Poverty

U.S. Census

*NHW=Non-Hispanic White, H=Hispanic, B=Black, O=Other
To be included in the study, each reported incidence record must meet the
following criteria:
1. A diagnosis of ALL per the International Classification of Diseases for
Oncology, 3rd edition (ICD-O-3).
2. Diagnosed between the years 1995-2009.
3. Diagnosed at age 14 years or younger.
4. Resident of Texas at the time of diagnosis.
5. No previously diagnosed malignant neoplasm.

37
No personal identifying information was requested or collected or used in any
way in this study. No contact was or was made with any individual or medical personnel.
All dates only include month and year for additional confidentiality. No individual case
was identified with a specific facility, or any specific individual facility total case counts
given.
Wright (1995) recommended 50 cases per predictor variable to achieve
appropriate statistical power in a logistic regression. Currently, there are 3,266 cases of
ALL in the TCR database that meet the study inclusion criteria. This cohort size greatly
exceeds the minimum required sample size to obtain accurate parameter estimates. In
addition, to detect a small effect size (r2=.01) given the three independent variables at a
statistical significance value of p < .01, Cohen (1992) calculated that 698 participants
would provide 80% power in a multiple logistic regression.
Research Methodology
Research Questions
1. What are the descriptive epidemiology statistics for childhood ALL in Texas?
These statistics included ALL incidence, mortality, and relative 5-year
survival rates for children 0-14 years of age residing in Texas diagnosed 19952009. As of this writing there are no published epidemiological statistics of
pediatric ALL specific to the Texas-Mexico border region.
2. Is there an association between COG facility affiliation and 5-year survival of
ALL?
Ho2: COG facility affiliation has no effect on 5-year survival of ALL.
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Ha2: COG facility affiliation has an effect on 5-year survival of ALL.
3. Is there an association between COG facility affiliation and 5-year survival of
ALL controlling for race, place of residence (border/nonborder), and poverty?
Ho3: There is no association between COG facility affiliation and 5-year
survival of ALL when controlling for race, place of residence, and poverty.
Ha3: There is an association between COG facility affiliation and 5-year
survival of ALL when controlling for race, place of residence and poverty.
Data Analysis
After application and approval from the Texas Department of State Health
Services, Texas Cancer Registry, ALL incidence data was provided in text file format for
convenient import into multiple software packages. Descriptive statistics were calculated
using SEER*Stat software from the National Cancer Institute (Table 2). Further analyses
were performed using Statistical Analysis System (SAS), version 9.4. Correlations
between binomial/categorical variables and COG affiliation were made using the chisquare test (Table 3). These variables included gender, race/ethnicity, geographic region,
and poverty status. Given at least three predictor variables of interest (facility affiliation,
area of residence, poverty status) pending the chi-square tests, logistic regression was
used to examine these variables in reference to the dependent variable of 5-year survival
(Tables 4 and 5). Odds ratios with 95% confidence intervals were calculated to assess the
strongest predictor(s) of survival. No censoring, loss to followup, or time to event
sequences were used or analyzed.
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Table 2
Childhood Acute Lymphocytic Leukemia, Texas, 1995-2009
Residence

Incidence

Mortality

5-Year Survival

Texas
Border
Nonborder
Note: All rates are age-adjusted to the 2000 US Census Standard.
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Table 3
Association of Type of Facility with Demographic Variables
Variable

COG, N =

Non-COG, N =

X²

Gender
Male
Female
Race/Ethnicity
White
Black
Hispanic
Other
Residence
Border
Nonborder
Poverty
>= 20%
< 20%

*P-value by chi-square for association between variables.
The variables for the logistic regression analysis were:


Dependent Variable: 5-year survival, yes/no



Independent Variable: COG Facility, yes/no



Independent Variable: Residence, border/nonborder



Independent Variable: Poverty Status >= 20%

P*
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Table 4
Logistic Regression with COG Facility
Source

B

SE

χ2

p

OR

95% CI for OR

COG Facility

B: slope
SE: standard error
χ2: test statistic
p: p-value
OR: Odds ratio
95% CI for OR: 95 percent confidence interval for odds ratio
Table 5
Logistic Regression with COG Facility, Residence, and Poverty
Source

B

SE

χ2

p

OR

95% CI for OR

COG Facility
Residence
Poverty
B: slope
SE: standard error
χ2: test statistic
p: p-value
OR: Odds ratio
95% CI for OR: 95 percent confidence interval for odds ratio

Summary
This chapter described the research methods to examine the survival of acute
lymphoblastic leukemia (ALL) among children living in Texas. The author wishes to
investigate the poorer survival of the disease among some children and if the type of
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treatment facility is associated with 5-year survival. ALL is a very treatable condition in
children and one of medicine's few major success stories against cancer. However, some
children in Texas may not be receiving the best care available. No child should be at a
disadvantage from such care. Chapter 4 presents the results to the specific research
questions.
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Chapter 4: Results
Introduction
The purpose of this quantitative retrospective epidemiologic study was to
determine if facilities in Texas with Children's Oncology Group (COG) affiliation offer
prognostic significance in pediatric acute lymphoblastic leukemia (ALL) survival. All
data used is the study were previously collected by the Texas Cancer Registry (TCR).
Texas law mandates that the state maintain a cancer registry. By Texas law cancer is a
reportable condition to the state cancer registry. All hospitals and treatment centers are
required to report each case diagnosed and/or treated. TCR is a member of the Centers for
Disease Control (CDC) National Program of Cancer Registries and the North American
Association of Central Cancer Registries (NAACR).
Datasets with no personal health information are available from TCR to the public
upon request. No personal health information was requested or used in this study. All
counts, rates, and analyses were calculated at aggregate levels. The TCR data-use
agreement requires that no aggregate data rates below the count of 16 individuals be
presented.
The initial selection criteria for the dataset was incident cases off ALL diagnosed
during the years 1995-2009 among children less than 15 years of age residing in the state
of Texas. This chapter first presents the descriptive epidemiological statistics of the study
population, and then examines variables associated with ALL survival.
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Variables
The variables used in this study were gender, race, ethnicity, diagnosis date,
county of residence, reporting facility, vital status, date of death, poverty status, and fiveyear survival. Poverty status was recorded from the United States Census Bureau based
on the geocoded census tract of resident address. Poverty was defined as census tracts
with > 20% poverty among residents. Five-year survival was defined as living at least
five years from the date of diagnosis. Date of death indicates the date the individual died,
or the date of last contact depending of the vital status being "alive" or "dead." The
examined dataset had complete vital status followup through 2014, thus allowing for
complete 5-year survival status of all included incident cases.
Reporting facilities were dichotomized into two groups based on affiliation with
the COG program. During the time of the study, COG member facilities were located in
the metropolitan areas of Amarillo, Lubbock, Dallas/Fort Worth, Temple, Austin, San
Antonio, Corpus Christi, and Houston. No COG facilities were located within the 32county border area. Border or nonborder county residence was based on the reported
county of residence at the time of diagnosis. Race/ethnicity were combined into four
groups of Non-Hispanic White, Black, Hispanic, and Other/Unknown.
Based on the study selection criteria, 3,266 records of ALL were received from
TCR. Incident counts for the variables of interest are given in Table 6. Of particular note
was of the 482 cases of ALL from the 32-county border area, 417 (86.5%) cases were
from just four counties: Hidalgo, El Paso, Cameron, and Webb.
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Table 6
Variable Counts, Childhood ALL, Ages 0-14 Years, Texas, 1995-2009
Variable

n

%

1,795
1,471

55.0
45.0

Hispanic
1,699
Non-Hispanic Black
204
Non-Hispanic White
1,225
Other or Unknown
138
Residence
Nonborder
2,784
Border
482
Poverty status
< 20%
2,125
>20%
1,141
Facility affiliation (COG)
No
259
Yes
3,007
5-Year Survival of ALL
No
453
Yes
2,813
Note. All percentages may not sum to 100 due to rounding error.

52.0
6.2
37.5
4.2

Sex
Male
Female
Race

85.2
14.8
65.1
34.9
7.9
92.1
13.9
86.1

Research Question 1
What are the descriptive epidemiology statistics of childhood ALL in Texas?
Using SEER*Stat software from the National Cancer Institute, the rates for incidence,
mortality, and 5-year survival were calculated (Table 7).
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Table 7
Childhood Acute Lymphocytic Leukemia Rates, Texas, 1995-2009
Residence

Incidence

Mortality

5-Year Survival

Texas

4.2

0.4

86.3%

Nonborder

4.1

0.3

87.8%

Border

5.1

0.9

77.5%

Note. All rates are per 100,000 and age-adjusted to the 2000 US Census Standard.

The overall ALL incidence rate was 4.2 per 100,000 population for children ages
0-14 years. The corresponding mortality rate for childhood ALL was 0.4 per 100,000
population. The incidence rate of childhood ALL in the 32-county border region was 5.1
per 100,000 population compared to 4.1 per 100,000 for the nonborder area of Texas.
Border area Hispanics had an incidence rate of 5.4 compared to 5.2 for nonborder
Hispanics. Childhood ALL mortality in the border area was 0.9 per 100,000 population
compared to 0.3 per 100,000 for the nonborder area of the state. The mortality rate for
border Hispanics was 0.9 compared to 0.5 for nonborder Hispanics.
While five-year survival in Texas was consistent with national statistics at 86.3%,
the 32-county border area was significantly lower for 5-year survival at 77.5%, and the
nonborder area slightly higher at 87.8%. A 2x2 chi-square analysis revealed this
difference was statistically significant, χ²(1) = 32.023, p < .001. In addition, the COG
participation rate for the border area was 56.2% compared to 98.3% for the nonborder
region of Texas.
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Research Question 2
Is there an association between facility affiliation and 5-year survival of ALL?
Ho2: Facility affiliation has no effect on 5-year survival of ALL.
Ha2: Facility affiliation has an effect on 5-year survival of ALL.
A series of chi-square tests of independence were conducted to examine the relationships
between sex, race, residence, poverty, and COG facility affiliation. The results are
presented in Table 8.
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Table 8
Association of Type of Facility with Demographic Variables
Variable

COG, N = 3,007

Non-COG, N = 259

0.05

Gender
Male

1,651 (50.6%)

144 (4.4%)

Female

1,356 (41.5%)

115 (3.5%)

Race/Ethnicity
White

1,190 (36.4%)

35 (1.1%)

Black

202 (6.2%)

2 (0.1%)

Hispanic
Other

1,480 (45.3%)
135 (4.1%)

Border
Nonborder

.830

120.18

<.001

995.10

<.001

144.55

<.001

3 (0.1%)

271 (8.3%)

211 (6.5%)

2,736 (83.8%)

48 (1.4%)

Poverty
>= 20%

p*

219 (6.7%)

Residence

< 20%

χ²

962 (29.5%)

179 (5.4%)

2,045 (62.6%)

80 (2.4%)

*P-value by chi-square for association between variables. Note. All percentages may not
sum to 100 due to rounding error.
Of all variables examined, only sex was not statistically significant, suggesting
sex and COG facility affiliation were not significantly associated with one another. Race,
residence, and poverty were all statistically significant, indicating a significant
association with COG facility participation.
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To address whether COG facility affiliation had an effect on 5-year survival of
ALL, logistic regression was conducted. Logistic regression is an appropriate statistical
analysis when assessing the predictive relationship between an independent variable and
a dichotomous outcome variable. Facility affiliation was entered into the model as the
predictor variable (1 = COG and 0 = Not COG). The outcome variable corresponded to
5-year survival of ALL (1 = Yes and 0 = No Survival). The results of the logistic
regression are presented in Table 9.
Table 9
Logistic Regression with COG Facility Affiliation Predicting Survival of ALL
Source

B

SE

Wald

p

OR

COG Facility
0.07
0.18
0.15
.699
1.07
Note. Overall model fit: χ2(1) = 0.15, p = .699, Nagelkerke R2 < .001

95% CI for OR
[0.75. 1.54]

The results of the logistic regression were not statistically significant, χ²(1) = 0.15,
p = .699, suggesting that COG facility affiliation alone was not significantly associated
with 5-year survival of ALL. As such, the null hypothesis cannot be rejected. Facility
affiliation alone does not have an effect on 5-year survival. Statewide, there was not a
statistically significant difference between patients being seen at COG-affiliated facilities
compared to facilities that were not COG affiliated.
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Research Question 3
Is there an association between COG facility affiliation and 5-year survival of
ALL controlling for race, place of residence, and poverty?
Ho3: There is no association between COG facility affiliation and 5-year survival
of ALL when controlling for race, place of residence, and poverty.
Ha3: There is an association between COG facility affiliation and 5-year survival
of ALL when controlling for race, place of residence, and poverty.
To address research question three, a logistic regression was conducted.
Residence, poverty status, race, and COG facility affiliation were entered into the model
as predictor variables. Residence was treated as a dichotomous response, with 1 = border
and 0 = nonborder. Poverty status was treated as a dichotomous response, with 1 =
poverty rate > 20% and 0 = poverty rate < 20%. Facility affiliation was treated as a
dichotomous response, with 1 = Yes (COG) and 0 = No (Non-COG). Due to race being a
categorical variable with four levels, the variable was dummy coded into three separate
dichotomous variables for comparison. During the dummy coding process, non-Hispanic
White was treated as the reference group. The outcome variable corresponded to 5-year
survival (1 = Yes and 0 = No). The results are presented in Table 10.
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Table 10
Logistic Regression with COG Facility, Residence, Poverty, and Race
Source

OR

95% CI for
OR

-0.71 0.16 19.32 <.001 0.49
Residence
-0.26 0.12 4.67
.031 0.77
Poverty status
Race (reference: White)
-0.18 0.13 2.00
.157 0.84
Hispanic
-0.36 0.21 2.91
.088 0.70
Black
0.57 0.36 2.56
.110 1.77
Other
-0.60 0.21 7.95
.005 0.55
Facility affiliation
2
Note. Overall model fit: χ (6) = 55.17, p < .001, Nagelkerke R2 = .030

[0.36, 0.68]
[0.61, 0.98]

B

SE

Wald

p

[0.65, 1.07]
[0.46, 1.06]
[0.88, 3.56]
[0.36, 0.83]

The overall regression model was statistically significant, χ2(6) = 55.17, p < .001,
suggesting that residence, poverty status, race, and facility affiliation have a significant
collective effect on survival of ALL. The regression coefficient for residence was
significant, B = -0.71, p < .001, OR = 0.49, indicating that for individuals on the border,
the odds of observing survival of ALL would decrease by approximately 49%. The
regression coefficient for poverty status was also significant, B = -0.26, p = .031, OR =
0.77, indicating that for individuals in poverty areas, the odds of observing survival of
ALL would decrease by approximately 77%. None of the race coefficients were
significant in the regression model. The regression coefficient for facility affiliation was
significant, B = -0.60, p = .005, OR = 0.55, suggesting that for participants with a COG
facility affiliation, the odds of observing survival of ALL would decrease by
approximately 55%. Due to significance of the overall model and the individual
predictor variables, the null hypothesis for research question three can be rejected. There
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was an association between COG facility affiliation and 5-year survival of childhood
ALL when controlling for race, place of residence, and poverty.
Multicollinearity can pose problems in regression models when intercorrelation
among multiple predictor variables is moderate or high (Stevens, 2009). Highly
correlated variables can result in inflated variances and unstable coefficient estimates. To
further explore these results, Variance Inflation Factors (VIFs) were calculated to detect
the presence of multicollinearity between the predictor variables. Variance Inflation
Factors greater than 5 are cause for concern, whereas VIFs of 10 should be considered the
maximum upper limit (Stevens, 2009). A score below 5 indicates little collinearity with
the other variables (Stevens, 2009). The VIF values for each dependent variable are
presented in Table 11.

Table 11
VIF Values for Predictor Variables
Source

VIF

Residence
Poverty Status
Race (reference: non-Hispanic White)
Hispanic
Non-Hispanic Black
Other
Facility Affiliation

1.72
1.33
1.43
1.12
1.07
1.44

All predictors in the regression model had VIFs less than 5, and thus there in no cause for
concern of multicollinearity in the model.
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To further assess the significant predictor variables, chi-square analyses were
conducted between residence and 5-year survival, and poverty and 5-year survival. The
results are presented in Table 12.

Table 12
Association of Residence and Poverty with ALL 5-Year Survival
Variable

No Survival

Survived

N = 453

N = 2,813

Residence
Border

346 (10.6%)

Nonborder

107 (3.3%)

χ²

p*

32.84

<.001

25.70

<.001

2,438 (74.6%)
375 (11.5%)

Poverty
< 20%

247 (7.6%)

1,878 (57.5%)

>= 20%

206 (6.3%)

935 (28.6%)

*P-value by chi-square for association between variables. Note. All percentages may not
sum to 100 due to rounding error.
Residence and poverty were both statistically significant, indicating a significant
association independently with childhood ALL 5-year survival. In addition, 2x2 chisquare analysis between residence and poverty revealed a statistically significant
association between the variables, χ²(1) = 535.39, p < .001.
To further examine the issue of COG facility participation given the extreme rate
difference between border (56.2%) and nonborder (98.3%) counties, a chi-square analysis
was conducted using only border data. This analysis revealed a statistically significant
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association between COG facility participation and childhood ALL 5-year survival,
χ²(1) = 9.35, p = .002. This calculation also produced a statistically significant odds ratio
of 2.0, 95% CI [1.3, 3.2]. While COG facility participation was not prognostic for 5-year
survival statewide, COG facility participation was associated with increased survival for
the 32-county border area.
Summary
The purpose of this study was to determine if facilities in Texas with COG facility
membership affiliation offer prognostic significance in pediatric ALL survival. Incidence
rates were consistent for Texas and the 32-county border and nonborder areas, and
consistent with national statistics. Mortality was higher in the predominantly Hispanic
border area while Hispanics in the nonborder area did not experience a significant
mortality difference from Texas or national ALL mortality rates.
Calculated 5-year survival rates revealed a statistically significant difference
between survival in the 32-county border area and the collective nonborder region of
Texas. In addition, the COG participation rate in the border area was 56%, far below the
nonborder area rate of 98% and the national SEER rate of 95%.
Descriptive statistics and chi-square tests of independence were used to examine
trends in the nominal level variables. The chi-square tests of independence determined
that there was a significant relationship between race, residence, poverty status, and
facility affiliation. The results of the logistic regression analysis for research question
two indicated that there was not a significant predictive relationship between COG
facility affiliation alone and survival of ALL statewide. The null hypothesis for research
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question two cannot be rejected. The results of the logistic regression for research
question three indicated that there was a collective predictive relationship between
residence, poverty status, race, COG facility affiliation, and survival of pediatric ALL. In
addition, three of the predictor variables, residence, poverty, and COG facility affiliation
were individually statistically significant in the regression model. The null hypothesis for
research question three can be rejected.
To further assess the stability of the regression model, Variance Indicator Factors
were calculated indicating no multicollinerarity between the predictor variables.
Additional chi-square tests were conducted to further investigate the relationship between
the significant predictor variables and childhood 5-year survival. An additional chisquare test was conducted to examine the association of COG facility participation and 5year survival in the 32-county border area. While COG facility participation was not
statistically significantly associated with 5-year survival statewide, the association was
statistically significant for the border area alone.
Chapter 5 will continue to discuss and interpret the findings of the data collection
and analyses. Connections will be made to the existing literature and theoretical
framework. Suggestions will also be provided for continued future research.

56
Chapter 5: Discussion, Conclusions, and Recommendations
Overview
The purpose of this study was to determine if facilities in Texas with Children's
Oncology Group (COG) affiliation offer prognostic significance in pediatric acute
lymphoblastic leukemia (ALL) survival. Among children ages 0-14 years, leukemia is the
most common malignancy with ALL accounting for 75% of those cases. While this
disease predominates in children, it is also one of the most curable malignancies with
expedient and proper diagnosis, treatment, and followup care. Pediatric oncology
research centers are the hallmark of such care, especially those that have achieved COG
membership.
During the time period of this study, 1995-2009, Texas was home to 12 COG
facilities located within eight metropolitan areas of the state. Those areas included the
cities of Dallas, Fort Worth, Houston, San Antonio, Austin, Lubbock, Amarillo, Temple,
and Corpus Christi. One area lacking a COG facility was the 32-county area of the TexasMexico border. The Texas-Mexico border area is home to over 2.5 million people, with
over 700,000 children and adolescents. Along with the extreme poverty of the area, this
geographic isolation poses a significant barrier to the comprehensive and complex
treatment needed to cure pediatric ALL. Health disparity studies among children are
much fewer compared to adults, and geospatial studies extremely lacking.
Race/ethnicity disparity studies among children diagnosed with ALL have been
conflicting in regards to survival. Population-based studies using Surveillance,
Epidemiology, and End Results (SEER) data from the National Cancer Institute have

57
revealed poorer survival for minorities. However, several facility-based studies have
shown no differences in survival with equal treatment. Texas data is not included in the
SEER dataset, and many studies examining racial disparities do not include Hispanics as
a separate group. This study of children in Texas was unique in that 52% of the cases
were recorded as Hispanic ethnicity. This was not surprising given Hispanics are the
fastest growing population in Texas and ALL incidence is slightly higher in Hispanic
children. A large Hispanic cohort along with the geospatial component and facility
affiliation allowed for the examination of variables lacking in the literature.
Summary of Findings
Incidence and mortality rates and 5-year survival were calculated for Texas, the
32-county border area, and the nonborder area of the state. Childhood ALL incidence was
consistent across Texas and both the border and nonborder areas, and consistent with
national statistics. The overall statewide mortality rate of 0.4 per 100,000 population for
childhood ALL in Texas was consistent with the United States rate of 0.3 per 100,000
population (ACS, 2013) for the same time period. Hispanics in the border and nonborder
area had similar incidence rates which were also consistent with national statistics.
However, the mortality rate in in the predominantly Hispanic 32-county border area of
0.9 per 100,000 population was three-times that of the mortality rate for the United
States. Nonborder area Hispanics did not experience significant increased mortality.
While 86.3% 5-year survival for childhood ALL in Texas was also consistent national
statistics of 85% (Pui, Pei, et al., 2012), survival in the border area (77.5%) was
statistically significantly lower when compared with the nonborder area (p < .001).
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The overall Texas COG participation rate for childhood ALL was 92.0%,
consistent with published studies using SEER data where over 90% of children under the
age of 15 years with cancer were seen at a COG facility (Hunger et al., 2013). However,
when examining the 32-county Texas-Mexico border area the COG participation rate for
children diagnosed with ALL was 56.2% compared to 98.3% for the nonborder area of
the state. The extremely low nonborder area COG participation rate surpasses any current
published studies.
Chi-square analyses were conducted comparing COG facility affiliation with the
other independent variables of gender, race/ethnicity, area of residence, and poverty
status. There was a statistically significant association (p < .001) between COG facility
affiliation and race/ethnicity, area of residence, and poverty status. There was no
association identified between COG facility affiliation and gender.
While the COG participation rate for the border area was far below the rate for the
nonborder area, COG facility affiliation alone was not a statistically significant predictor
of 5-year survival. Logistic regression was performed using only COG facility affiliation
as a dependent variable and 5-year survival as the outcome. As a result the null
hypothesis of research question two cannot be rejected. There was no evidence that COG
facility affiliation alone was associated with 5-year survival of childhood ALL statewide.
Logistic regression was then conducted adding race, residence, and poverty
status to the model. The overall regression model was statistically significant (p < .001)
suggesting that residence, poverty status, race, and COG facility affiliation had a
significant collective effect on 5-year survival of childhood ALL. The coefficients for
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residence, poverty status, and COG facility affiliation were all individually significant,
while the coefficient for race/ethnicity was not. Race and Hispanic ethnicity were not
statistically significant factors in ALL survival.
Due to significance of the overall model and three individual predictor variables,
the null hypothesis for research question was rejected. There was an association between
COG facility affiliation and 5-year survival of childhood ALL when controlling for race,
place of residence, and poverty.
It was surprising to find that overall in Texas, COG affiliation actually decreased
the chance of 5-year survival. When examining the data, this result was due to the
overwhelming 98.3% COG participation rate in the nonborder area of the state. In the
United States, about 15% of children do not survive ALL (Pui, Pei, et al., 2012). Texas
fared slightly better during the 1995-2009 time period at 86.3% 5-year survival. Most of
those deaths occurred in the nonborder area of the state, and among individuals who had
been seen at a COG facility. This paradox is discussed more thoroughly in the next
section.
To further assess the predictor variables in the regression model, chi-square was
conducted between residence and survival, poverty status and survival, and residence and
poverty status. All three associations were statistically significant (p < .001).
Interpretation of Findings
This study set out to investigate COG facility affiliation and 5-year survival of
childhood ALL in Texas. Of particular interest was survival and COG utilization in the
32-country Texas-Mexico border area, a known region of poverty and limited medical
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resources. During the time of the study (1995-2009), no COG membership facilities were
located within the 32-county border area, while the nonborder area of the state was home
to 12 COG facilities.
The 56.2% COG participation rate for the border area was far below the 98.3%
participation rate for the nonborder area and 90-95% published participation rates for the
United States. Chi-square revealed a statistically significant association between area of
residence and COG facility affiliation (p < .001). In addition, childhood ALL mortality in
the border area was three times that of the nonborder area of the state. Five-year survival
was statistically significantly lower in the border area when compared the nonborder area
of the state. The 77.5% 5-year survival rate in the border area would be comparable to
United States figures from the 1970s. There was clearly a disparity in Texas for
childhood ALL 5-year survival in the 32-county Texas-Mexico border area with just over
half of children diagnosed being seen at a COG affiliated facility.
However, COG facility membership alone did not explain the survival disparity.
When examined individually, COG facility membership alone was not statistically
significantly associated with 5-year survival of childhood ALL in Texas. Upon
examining the data, the reason for this becomes clear.
While the nonborder area of the state recorded 98.3% COG participation, 5-year
survival was only 87.8%. Children diagnosed will ALL in this part of the state were
visiting COG facilities but many did not achieve 5-year survival. The reasons for this
cannot be determined from this study. But possible explanations are adherence to
treatment regimens and following a complete treatment protocol with followup. This
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study only examined if the child was at least seen at a COG facility. Others factors could
include distance to care from rural areas, timely diagnosis, and unfavorable biological
disease characteristics at time of diagnosis, such as T-cell ALL which has a poorer
prognosis (Dores, Devesa, Curtis, Linet, & Morton, 2012). The vast majority of children
diagnosed will ALL in the nonborder area were seen at a COG facility and thus the nonCOG comparison group was very small.
In addition, while the 32-county border area only experienced 56.2% COG
participation, many children did survive 5 years, although overall 5-year survival for the
population was poor at 77.5%. While general ALL treatment protocols have been shown
to be not as effective as individual risk-based designed protocols, standardized treatments
can produce positive results. In 2004 Children's Hospital in Houston opened a satellite
treatment clinic in the city of McAllen, located in Hidalgo County where 165 of the
border area cases in this study were diagnosed. Adjacent Cameron County accounted for
another 82 cases. This clinic may have proved beneficial for children diagnosed with
ALL in that area. These types of clinics and "treatment sharing" have proved effective
even in developing countries (Aristizabal et al., 2015). Such treatments may have also
been used in the major hospitals in El Paso, where 131 of the cases were located. In 2015,
facilities in both El Paso and McAllen received full COG membership affiliation.
However, when border-only data were examined, COG facility participation not only
becomes a statistically significant variable, but with a positive association towards
survival. Children diagnosed with ALL residing in the 32-county border area seen at a
COG facility were two-times more likely to survive than those not seen at a COG facility.
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Overall, of the 453 cases of childhood ALL in Texas that did not achieve 5-year
survival, only 38 were not seen at a COG facility. However, 33 of those non-COG
affiliated deaths were cases from the 32-county border area. A much higher percentage
(98.6%) of cases seen at a COG facility that did not achieve 5-year survival occurred in
the nonborder area of the state. In the border area COG-affiliated cases only accounted
for 69.2% of the cases that did not survive 5 years. While COG affiliation alone was not
significant statewide when associated with childhood ALL 5-year survival, 30.8% of the
cases that did not survive in the border area were not seen at a COG facility compared to
1.4% for the nonborder area.
In the final regression model, COG facility affiliation actually had a statistically
significant but negative association with childhood ALL 5-year survival. Many children,
even though seen at a COG facility, did not survive. In the United States 10-15% of
children diagnosed with ALL do not survive (Pui, Pei, et al., 2012). In Texas for the years
1995-2009, 13.7% of children diagnosed with ALL did not survive five years, yet 91.6%
of those cases were seen at a COG facility. This high participation rate actually skews the
association in a negative direction. The fact that poverty was a significant factor
statewide in 5-year survival must be considered with this observation. One can only
hypothesize what the survival rate would be without such high COG participation.
Both region of residence (border, nonborder) and poverty status were statistically
significantly associated with childhood ALL survival. Living in the border area and in
poverty both decrease chances for survival. And unlike COG facility participation, these
variables were both independently statistically significantly associated with childhood
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ALL survival in chi-square analyses. Poverty and region of residence are stronger
predictors of childhood ALL 5-year survival than COG facility affiliation statewide. The
significant association between all three of those variables when combined sets the stage
for a perfect storm. For children in Texas diagnosed with ALL residing in the 32-county
Texas-Mexico border area, living in a neighborhood with high poverty, and not being
seen at a COG facility, survival can be predicted to be much poorer.
The major limitation of this study is there was no documentation of full treatment
and followup. Full treatment of ALL can last up to three years. This study only
documented children residing in Texas diagnosed with ALL being seen at least one time
at a COG facility. Another limitation was that even with 15 years of data, only 3,266
cases were collected. Pediatric ALL is a rare condition and multiple years of data are
require to assemble even a small dataset. These data did reveal a major health disparity in
the 32-county Texas-Mexico border area. The 77.5% ALL survival for the 32-county
border area is consistent with national rates 40 years ago.
Theoretical Basis of the Study
Krieger's model of ecosocial theory (Krieger, 2001) was the theoretical basis of
this study. The driving hypothesis behind this research was that geographical isolation as
a barrier to the best risk-based treatment is more a factor in pediatric ALL survival than
poverty or Hispanic ethnicity. Ecosocial theory examines the relationships between
biological, social, political, and economic aspects of population patterns of not only
disease, but well-being.
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Analyses of Texas childhood ALL data 1995-2009 revealed no statistically
significant association between gender or race/ethnicity and 5-year survival. Statewide
poverty and area of residence were associated with poorer survival. Residing in the
border area and living in a poor neighborhood were both predictors of poor survival. In
addition, while not significant statewide, COG facility participation was significant in the
border area and was associated with increased survival. These results describe an area of
great health disparity due to social and economic factors. The poverty of the TexasMexico border area and lack of access to the best and equal care were associated with
poorer survival.
Future Recommendations
This study examined ALL diagnosed among children ages 0-14 years residing in
the state of Texas 1995-2009. A large health disparity was identified among children
residing in the 32-county Texas-Mexico border region. These children experience poorer
outcomes when compare to those who reside in the nonborder area of the state, resulting
in mortality from a curable disease.
This study was limited in using population-based data previously collected from
the Texas Cancer Registry. Further studies are needed to examine why so many children
in the Texas-Mexico border region diagnosed with ALL are not receiving the best care
possible. The vast distance distances to these facilities and available resources are no
doubt factors. But other social factors such as trust and lack of education could also be
involved in not seeking expert treatment. The thought of traveling with a very sick child
to some of the largest cities in the country hundreds of miles from home is obviously an
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extremely frightening situation. Even when these expert care facilities fully treat children
with cancer regardless of a family's ability to pay, also including ancillary expenses such
as lodging, travel, and food, many children do not get the best care available.
A more detailed geospatial study is needed to assess rural/urban differences and
actual distances between residence and treatment facilities. Even in the nonborder region
of the state, many rural counties are far away from major metropolitan areas. This could
be achieved using geocoded data of residence and treatment facility.
In 2015 two facilities in the 32-county Texas-Mexico border region received
COG membership. El Paso and McAllen, two of the largest populated areas of the region,
now are home to a COG facility. Future studies are needed to examine the effect of these
facilities on the poorer ALL survival of the region, and further interventions applied if
necessary. Even with these two new COG designations, complete treatment and followup
must occur for the best outcomes. As the data become available, 10-year survival studies
need to be conducted to assess that a full cure was achieved. Not only is initial and
expedient diagnosis critical and the best precise risk-based treatment applied, but that the
full treatment protocol is diligently followed, including annual followup for 10 years.
Implications for Social Change
Acute lymphoblastic leukemia (ALL) is the most common cancer among children
ages 0-14 years in the United States (Hunger et al., 2012). Fortunately it is also one of
science's greatest triumphs against cancer, with 5-year survival exceeding 95% with the
best treatments available (Pui, Pei, et al., 2012). Some facilities have even achieved the
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cure standard of 10 years at 90% (Pui & Evans, 2013). Still, ALL remains the leading
cause of cancer mortality in children less than 15 years of age. (Hunger et al., 2013).
Unfortunately some children in the United States do not access and experience the
care needed for such great achievements. This study has identified such a population.
Children residing in the Texas-Mexico border area diagnosed 1995-2009 with ALL only
achieved 77.5% 5-year survival. This study has the potential to promote positive social
change in revealing such disparities, and hopefully increasing the understanding of
childhood ALL and the need for expert, individual-based treatment. These data revealed
that the reasons for poorer survival are associated with the social factors of poverty and
access to care. Such social and cultural factors must be considered along with the latest
evidence-based medicine for the best outcomes.
Conclusion
Prior to the 1960s a diagnosis of acute lymphoblastic leukemia (ALL) in a child
was a literal death sentence. While men were walking on the moon, physicians and
scientists were diligently trying to achieve a cure for the most common childhood cancer.
Now in the United States 85.5% of children diagnosed with the horrible disease can be
cured (Ma, Sun, & Sun, 2014). For the most advanced pediatric oncology research
centers, 95% of children who receive full treatment and followup care are cured. Over
200 of these facilities in the United States form the Children's Oncology Group (COG).
Yet for many children in the United States, obtaining care at one of these facilities
remains very difficult. This study has revealed such a population, and poorer survival of
pediatric ALL among children 0-14 years of age. Almost half the children diagnosed with
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ALL 1995-2009 who resided in the 32-county area along the Texas-Mexico border were
not seen at pediatric oncology research center. This area is also plagued by high poverty
rates, creating additional barriers to care. And while poverty occurs statewide in Texas,
over 98% of children diagnosed with ALL in the nonborder region of the state were seen
at a COG facility. Being predominantly Hispanic and a border area, cultural and social
factors are involved, as well. For some children today, even with the advanced treatments
available a diagnosis of ALL can still be a death sentence. Unlike many adult cancers
where lifestyle changes and screening are associated with improved survival, accurate
diagnosis and expedient treatment are the main factors involved with pediatric ALL
survival. Inherited genetics, a hallmark risk factor in adult cancers, has only been
associated with about 5% of pediatric ALL cases (Spector, Charbonneau, & Robison,
2012). The best care available after diagnosis is the only plan for a child to survive the
disease. This must be considered as the United States struggles with how to deliver the
best healthcare to its population, and who should or should not be a part of that
population.
In 1971 President Richard M. Nixon issued the ambitious challenge to cure a
group of diseases that had longed plagued mankind. Just as President John F. Kennedy
had declared to make travel to the moon a reality just 10 years prior, Nixon called on the
best scientists and researchers in the country to conquer cancer (DeVita, 2002). Nixon
later signed the National Cancer Act of 1971 which mandated eliminating the disease an
issue of national importance (DeVita, 2002). The “War on Cancer” as it would be later
known, had officially begun, and almost 50 years later continues.

68
References
Altman, A. J., & Fu, C. (2011). Chronic leukemias of childhood. In P. A. Pizzo & D. G.
Poplack (Eds.), Principles and Practice of Pediatric Oncology (6th ed., pp.611637). Philadelphia, PA: Lippincott Williams & Wilkins.
American Academy of Pediatrics (2009). Long-term follow-up care for pediatric cancer
survivors. Pediatrics, 123(3), 906-915.
American Cancer Society (2012). Cancer Facts & Figures for Hispanics/Latinos 20122014. Atlanta, GA: Author.
American Cancer Society (2016). Cancer Facts & Figures 2016. Atlanta, GA: Author.
Aristizabal, P., Fuller, S., Rivera, R., Beyda, D., Ribeiro, R. C., & Roberts, W. (2015).
Improving pediatric cancer care disparities across the United States-Mexico
border: lessons learned from a transcultural partnership between San Diego and
Tijuana. Frontiers in Public Health, 159(3), 1-9.
Barrington-Trimis, J. L., Cockburn, M., Metayer, C., Gauderman, W. J., Wiemels, J., &
McKean-Cowdin, R. (2015). Rising rates of acute lymphoblastic leukemia in
Hispanic children: trends in incidence from 1992 to 2011. Blood, 125(19), 30333034.
Behringer, B., Friedell, G. H., Dorgan, K. A., Hutson, S. P., Naney, C., Phillips,
A.,…Cantrell, E. S. (2007). Understanding the challenges of reducing cancer in
Appalachia: addressing a place-based health disparity population. Californian
Journal of Health Promotion, 5(Special Issue on Health Disparities and Social
Justice), 40-49.

69
Bhatia, S. (2011). Disparities in cancer outcomes: lessons learned from children with
cancer. Pediatric Blood & Cancer, 56(6), 994-1002.
Bona, K., Dussel, V., Oreliana, L., Kang, T., Geyer, R., Feudtner, C., Wolf, J. (2014).
Economic impact of advanced pediatric cancer on families. Journal of Pain
Symptom Management, 47(3), 594-603.
Byers, T. E., Wolf, H. J., Bauer, K. R., Bolick-Aldrich, S., Chen, V., Finch, J. L, et al.
(2008). The impact of socioeconomic status on survival after cancer in the United
States. Cancer, 113(3), 582-591.
Carroll, W, L., Bhojwani, D., Min, D. J., Raetz, E., Relling, M., Davies, S., et al. (2003).
Pediatric acute lymphoblastic leukemia. Hematology, 50(1), 102-131.
Children's Oncology Group (2015). Children's Oncology Group Hospitals in Texas.
Retrieved from www.childrensoncologygroup.org.
Children's Oncology Group (2016). Retrieved from
www.childrensoncologygroup.org/index.php/aboutus
Cohen, J. (1992). A power primer. Psychology Bulletin, 112(1), 155-159.
Cure Search (2009, November 8). COG institutions in Texas. Retrieved from
www.curesearch.org/resources/coglist.aspx?State=TX&lc=
DeVita, V. T., Jr. (2002). A perspective of the war on cancer. Cancer Journal, 8(5), 352356.
Diller, L. (2011). Adult primary care after childhood acute lymphoblastic leukemia. The
New England Journal of Medicine, 365(15), 1417-1424.

70
Dores, G. M., Devesa, S. S., Curtis, R. E., Linet, M. S., & Morton, L. M. (2012). Acute
leukemia and patient survival among children and adults in the United States,
2001-2007. Blood, 119(1), 34-43.
Eberhardt, M. S., Ingram, D. D., Makuc, D. M., Pamuk, E. R., Freid, V. M., Harper, S.
B., et al. (2001). Urban and Rural Chartbook. Health United States, 2001.
Hyattsville, MA: National Center for Health Statistics.
Flores, G. (2010). Technical report: racial and ethnic disparities in the health and health
care of children. Pediatrics, 125(4), e979-e1020.
Ford, G. F., Howerton, M. W., Lai, G. Y., Gary, T. L., Bolen, S., Gibbons, M. C., et al.
(2008). Barriers to recruiting underrepresented populations to cancer clinical
trials: A systematic review. CA: A Cancer Journal for Clinicians, 112(2), 228242.
Galster, G. (2012). The mechanisms of neighborhood effects: theory, evidence, and
policy implications. In M. van Ham, D. Manley, N. Bailey, L. Simpson, & D.
MacLennan (Eds.), Neighborhood Effects Research: New Perspectives (pp.2356). Dordrecht, Netherlands: Springer.
Gatta, G., Capocaccia, R., Stiller, C., Kaatsch, P., Berrino, F., & Terenziani, M. (2005).
Childhood cancer survival trends in Europe: a EUROCARE working group study.
Journal of Clinical Oncology, 23(16), 3742-3751.
Goggins, W. B., & Lo, F. F. K. (2012). Racial and ethnic disparities in survival of US
children with acute lymphoblastic leukemia: evidence from the SEER database
1988-2008. Cancer Causes and Control, 23(5), 737-743.

71
Goodwin, J. S., Freeman, J. L., Mahnken, J. D., Freeman, D. H., & Nattinger, A. B.
(2002). Geographic variations in breast cancer survival among older women:
implications for quality of breast cancer care. The Journals of Gerontology Series
A: Biological and Medical Sciences 57(6), M401-406.
Gutierrez, J. C., Cheung, M. C., Zhuge, Y., Koniaris, L. G., & Sola, J. E. (2010). Does
Children's Oncology Group hospital membership improve survival for patients
with neuroblastoma or Wilms tumor? Pediatric Blood and Cancer, 55(4), 621628.
Health Grades (2009, November 23). Pediatric oncology and pediatric hematology
doctors and physicians. Retrieved from http://www.healthgrades.com/localdoctors-directory/by-specialty/pediatric-oncology-pediatric-hematology
Hossain, M. J., Xie, L., & McCahan, S. M. (2014). Characterization of pediatric acute
lymphoblastic leukemia survival patterns by age at diagnosis. Journal of Cancer
Epidemiology, 2014, 1-9.
Howell, D. L, Ward, K. C., Austin, H. D., Young, J. L, Woods, W. G. (2007). Access to
pediatric cancer care by age, race, and diagnosis, and outcomes of cancer
treatment in pediatric and adolescent patients in the state of Georgia. Journal of
Clinical Oncology, 25(29), 4610-4615.
Howlader, N., Noone, A. M., Krapcho, M., Garshell, J., Miller, D., Altekruse, S. F., et al.
(Eds.). (2014). SEER Cancer Statistics Review, 1975-2011. Bethesda, MA:
National Cancer Institute.

72
Howlader, N., Noone, A. M., Krapcho, M., Miller, D., Bishop, K., Altekruse, S.F., et al.
(Eds.). (2016). SEER Cancer Statistics Review, 1975-2013. Bethesda, MA:
National Cancer Institute.
Hunger, S. P., Loh, M. L., Whitlock, J. A., Winick, N. J., Carroll, W. L., Devidas, M.,…
Raetz, E. A. (2013). Children’s Oncology Group’s 2013 blueprint for research:
acute lymphoblastic leukemia. Pediatric Blood & Cancer, 60(6), 957-963.
Hunger, S. P., Lu, X., Devidas, M., Camitta, B. M., Gaynon, P. S., Winich, N. J.,…
Carroll, W. L. (2012). Improved survival for children and adolescents with acute
lymphoblastic leukemia between 1990 and 2005: A report from the Children’s
Oncology Group. Journal of Clinical Oncology, 30(14), 1663-1669.
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010). Cancer statistics, 2010. CA: A Journal
for Clinicians, 60(1), 277-300.
Kadan-Lottick, N. S., Ness, K. K., Bhatia, S., & Gurney, J. G. (2003). Survival variability
by race and ethnicity in childhood acute lymphoblastic leukemia. Journal of the
American Medical Association, 290(15), 2008-2014.
Kagawa-Singer, M., Dadia, A. V., Yu, M. C., & Surbone, A. (2010). Cancer, culture, and
health disparities. Time to chart a new course? CA: A Cancer Journal for
Clinicians, 60(1), 12-39.
Kent, E. E., Sender, L. S., Largent, J. A., & Anton-Culver (2009). Leukemia survival in
children, adolescents, and young adults: influence of socioeconomic status and
other demographic factors. Cancer Causes & Control, 20(8), 1409-1420. Laszlo,

73
J. (1995). The cure of childhood leukemia – into the age of miracles. New
Brunswick, NJ: Rutgers University Press.
Krieger, N. (2001). Theories for social epidemiology in the 21st Century: an ecosocial
perspective. International Journal of Epidemiology, 30(4), 668-677.
Krieger, N. (2002). A glossary for social epidemiology. Epidemiological Bulletin, 23(1),
7-11.
Krieger, N. (2013). Epidemiology and the People's Health: Theory and Context. New
York, NY: Oxford University Press.
McCarthy, D., How, S. K. H., Schoen, C., Cantor, J. C., & Belloff, D. (2009). Aiming
higher: results from a state scorecard on health system performance, 2009. New
York, NY: The Commonwealth Fund.
Lichtman, M. A. (2008). Battling the hematological malignancies: the 200 year’s war.
The Oncologist, 13(2), 126-138.
Liu, L., Krailo, M., Reaman, G. H., & Bernstein, L. (2003). Childhood cancer patient’s
access to cooperative group cancer programs. Cancer, 97(5), 1339-1345.
Ma, H., Sun, H., & Xiaoping, S. (2014). Survival improvement by decade of patients
aged 0-14 years with acute lymphoblastic leukemia: A SEER analysis. Scientific
Reports, 4(4227), 1-7.
Margolin, J. F., Rabin, K. R., Steuber, C. P., & Poplack, D. G. (2011). Acute
lymphoblastic leukemia. In P. A. Pizzo & D. G. Poplack (Eds.), Principles and
Practice of Pediatric Oncology (6th ed., pp.518-565). Philadelphia, PA:
Lippincott Williams & Wilkins.

74
Meadows, A. T., Kramer, S., Hopson, R., Lustbader, E., Jarret, P., Evans, A. E. (1983).
Survival in childhood acute lymphoblastic leukemia: effect of protocol and place
of treatment. Cancer Invest, 1(1), 49-55.
Mertens, A. C. (2007). Cause of mortality in 5-year survivors of childhood cancer.
Pediatric Blood and Cancer, 48(7), 723-726.
Mody, R., Suwen, L., Dover, D. C., Sallan, S., Leisenring, W., Oeffinger, K. C., et al.
(2008). Twenty-five year follow-up among survivors of childhood acute
lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study.
Blood, 111(12), 5515-5523.
Oeffinger, K. C., Mertens, A. C., Sklar, C. A., Kawashima, T., Hudson, M. M.,
Meadows, A. T., et al. (2006). Chronic health conditions in adult survivors of
childhood cancer. Results from the childhood cancer survival study. New England
Journal of Medicine, 355(15), 1572-1582.
O’Leary, M., Krailo, M., Anderson, J. R., & Reaman, G. H. (2008). Progress in
childhood cancer: 50 years of research collaboration, a report from the Children’s
Oncology Group. Seminars in Oncology, 35(5), 484-493.
Onciu, M., & Pui, C. H. (2012). Diagnosis and classification. In C. H. Pui (Ed.),
Childhood Leukemias (3rd ed., pp.21-48). New York, NY: Cambridge University
Press.
Pui, C. H. (2012). Acute lymphoblastic leukemia. In C. H. Pui (Ed.), Childhood
Leukemias (3rd ed., pp. 332-366). New York, NY: Cambridge University Press.

75
Pui, C. H., Campana, D., Pei, D., Bowman, W. P., Sandlund, J. T., Kaste, S. C., et al.
(2009). Treating acute childhood acute lymphoblastic leukemia with cranial
irradiation. New England Journal of Medicine, 360(26), 2730-2741.
Pui, C. H., Mullighan, C. G., Evans, W. E., & Relling, M. V. (2012). Pediatric acute
lymphoblastic leukemia: where are we going and how do we get there? Blood,
120(6), 1165-1174.
Pui, C. H., Pei, D., Pappo, A. S., Howard, S. C., Cheng, C., Sandlund, J. T., et al. (2012).
Treatment outcomes in black and white children with cancer; results from SEER
database and St. Jude Children’s Research Hospital, 1992 through 2007. Journal
of Clinical Oncology, 30(13), 1-9.
Pui, C. H., Sandlund, J. T., Pei, D., Rivera, G. K., Howard, S. C., Ribeiro, R. C., et al.
(2003). Results of therapy for acute lymphoblastic leukemia in black and white
children. JAMA, 290(15), 2001-2007.
Rivera, J. O., Ortiz, M., Cardenas, V. (2009). Cross-border purchase of medications and
health care in a sample of residents of El Paso, Texas, and Ciudad Juarez, Mexico.
Journal of the National Medical Association, 101(2), 167-173.
Robison, L. L. (2011). Late effects of acute lymphoblastic leukemia therapy in patients
diagnosed at 0-20 years of age. (Hematology, 2011(1), 238-242.
Sant, M., Allemani, C., Santaquilani, M., Knijn, A., Marchesi, F., & Capocaccia, R.
(2009). EUROCARE -4. Survival of cancer patients diagnosed in 1995-1999:
results and commentary. European Journal of Cancer 45(6), 931-991.

76
Schillinger, J. A., Grosclaude, P. C., Honjo, S., Quinn, M. J., Slogggett, A., & Coleman,
M. P. (2011). Survival after acute lymphoblastic leukemia: effects of
socioeconomic status and geographic region. Archive of Diseases of in Childhood,
80(4), 311-317.
SEER (2009, December 1). Overview of the SEER program. Retrieved from
http://seer.cancer.gov/about/
Seibel, N. L. (2008). Treatment of acute lymphoblastic leukemia in children and
adolescents: peaks and pitfalls. Hematology, 2008(1), 374-380.
Siegel, R., Naishadham, D., & Jemal, A. (2012). Cancer statistics, 2012. CA: A Journal
for Clinicians, 62(1), 10-29.
Stevens, J. P. (2009). Applied Multivariate Statistics for the Social Sciences (5th ed.).
Mahwah, NJ:Routledge Academic.
Spector, L. G., Charbonneau, B., and Robison, L. L. (2012). Epidemiology and etiology.
In C. H. Pui (Ed.), Childhood Leukemias (3rd ed., pp. 49-71). New York, NY:
Cambridge University Press.
St. Jude Children’s Research Center (2010, February 6). Leukemia/lymphoma parent
information. Retrieved from
http://www.stjude.org/stjude/v/index.jsp?vgnextoid=03cdfa3186e70110VgnVCM
1000001e0215acRCRD&vgnextchannel=e009bfe82e118010VgnVCM1000000e2
015acRCRD
Texas Cancer Registry (2010, May 05). Welcome to the Texas Cancer Registry.
Retrieved from http://www.dshs.state.tx.us/tcr/default.shtm

77
Texas Cancer Registry (2014, January 14). Cancer Reporting Law and Rules. Retrieved
from http://www.dshs.state.tx.us/tcr/lawrules.shtm
Texas Children’s Hospital (2010, February 18). Acute lymphoid leukemia in infants.
Retrieved from
http://www.texaschildrens.org/Parents/TipsArticles/ArticleDisplay.aspx?aid=104
7
Texas Secretary of State (2014, July 7). Texas Colonias: A Thumbnail Sketch of
Conditions, Issues, Challenges, and Opportunities. Retrieved from
http://www.sos.state.tx.us/border/colonias/faqs.shtml
Torpy, J. M., Lynm, C., & Glass, R. M. (2009). Acute lymphoblastic leukemia. Journal
of the American Medical Association, 301(4), 452.
Urban Institute (2010, May 06). Children of immigrants: facts and figures. Retrieved
from http://www.urban.org/publications/900955.html
U. S. Census Bureau (2010, December). Small area income and poverty estimates.
http://www.census.gov/did/www/saipe/about/index.html
U. S. Census Bureau (2013, June 28). State and county quick facts. Retrieved from
http://quickfacts.census.gov/qfd/states/48000lk.html
U. S. Department of Health and Human Services (2000). Healthy People 2010:
Understanding and Improving Health (2nd ed.). Atlanta, GA: Author.
U. S. Department of Health and Human Services (2012). Healthy People 2010: Final
Review. Atlanta, GA: Author.

78
Van Dis., J. (2002). Where we live; health care in rural vs urban America. Journal of the
American Medical Association, 287(1), 108.
Wingo, P. A., Tucker, T. C., Jamison, P. M., Martin, H., McLaughlin, C., Bayakly, R.,
Bolick-Aldrich, S., et al. (2008). Cancer in Appalachia, 2001-2003. Cancer,
112(1), 181-192.
Wolff, J. A. (1991). History of pediatric oncology. Pediatric Hematology and Oncology,
8(2), 89-91.
Youlden, D. R., Baade, P. D., Valery, P. C., Ward, L. J., Green, A. C., & Aitken, J. F.
(2011). Differentials in survival for childhood cancer in Australia by remoteness
of residence and area disadvantage. Cancer Epidemiology, Biomarkers, &
Prevention 20(8), 1649-1656.
Zeltzer, L. K., Recklitis, C., Buchbinder, D., Zebrack, B., Casillas, J., Tsao, J. C. I., et al.
(2009). Psychological status in childhood cancer survivors: A report from the
childhood cancer survivor study. Journal of Clinical Oncology, 27(14), 23962404.

79
Appendix A: List of the 32 Texas-Mexico Border Counties
Brewster
Brooks
Cameron
Crockett
Culberson
Dimmit
Duval
Edwards
El Paso
Frio
Hidalgo
Hudspeth
Jeff Davis
Jim Hogg
Kenedy
Kinney
La Salle
McMullen
Maverick
Pecos
Presidio
Real
Reeves
Starr
Sutton
Terrell
Uvalde
Val Verde
Webb
Willacy
Zapata
Zavala

